MOSCOW: The ever increasing prices for drugs in Russia could be explained by the existing cartels, which have been created in the domestic pharmaceutical market by some global drugmakers and their distributors, according to recent statements of Igor Artemiev, head of the Russian Federal Antimonopoly Service (FAS). Mr Artemiev said that prices for drugs that contain the same substances, but are sold in Russia under different brands in some cases, are overestimated by 160 times, reports The Pharma Letter’s local correspondent. Mr Artemiev has also said that there are “thousands of cartels” on the Russian pharmaceutical market, pointing out that the majority of tenders in this field are conducted with serious violations. Finally, Mr Artemiev said that many global drugmakers operating in Russia are “imposing their practices” that lead to an increase in the cost of drugs in the local market.
lamic banking assets reach Rs14.47 trillion, sector share rises to 23%
KARACHI: Pakistan’s Islamic banking sector expanded during 2025, increasing its share in the country’s financial system with assets reaching nearly...
